News

Jones Healthcare Group, a market leader in advanced packaging and medication dispensing solutions, announces a significant investment in its packaging services offering including a new, fully integrated two-lane Uhlmann blister packaging line. The highly automated equipment will enhance the...

SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals and vaccines, has unveiled a $143 million agreement with the federal government. The agreement with the Department of Defense’s Joint Program Executive...

Berkshire Sterile Manufacturing took another step toward an ambitious $20 million expansion plan when it recently closed on the majority of the project’s financing. The firm, which has been playing a role in developing medications used to treat patients with...

UCB announced the acquisition of Engage Therapeutics, Inc., a clinical-stage pharmaceutical company developing Staccato®Alprazolam for the rapid termination of an active epileptic seizure, for US$ 125 million in cash (subject to certain adjustments) and up to US$ 145 million...

On 16 June, Lonza will host a free 60-minute webinar on the latest regulatory developments surrounding the use of the recombinant Factor C (rFC) assay for endotoxin detection in parenteral pharmaceuticals and implantable medical devices. During the webinar, Allen...

Albumedix Ltd., the world leader in recombinant human albumin (rAlb), announced the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020. This announcement follows the recent appointment of...

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquisition of Alderley Oncology, a focused in vivo pharmacology service provider which undertakes high quality in vivo...